(Q51969642)

19 April 2018

title

Therapy-induced antitumor vaccination by targeting tumor necrosis factor alpha to tumor vessels in combination with melphalan. (English)

1 reference

19 April 2018

Roberto S Accolla

9

0 references

author name string

Lorenzo Mortara

1

1 reference

19 April 2018

Enrica Balza

2

1 reference

19 April 2018

Francesca Sassi

3

1 reference

19 April 2018

Patrizia Castellani

4

1 reference

19 April 2018

Barbara Carnemolla

5

1 reference

19 April 2018

Andrea De Lerma Barbaro

6

1 reference

19 April 2018

Sara Fossati

7

1 reference

19 April 2018

Giovanna Tosi

8

1 reference

19 April 2018

Laura Borsi

10

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 December 2007

1 reference

19 April 2018

European Journal of Immunology

published in

1 reference

19 April 2018

volume

37

1 reference

19 April 2018

issue

12

1 reference

19 April 2018

page(s)

3381-3392

1 reference

19 April 2018

Adoptive-cell-transfer therapy for the treatment of patients with cancer

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

IL-12 and IL-10 expression synergize to induce the immune-mediated eradication of established colon and mammary tumors and lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

The use of dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Tumor-induced immune dysfunctions caused by myeloid suppressor cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Interleukin-10-induced T cell unresponsiveness can be reversed by dendritic cell stimulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Down-regulation of TGF-beta1 production restores immunogenicity in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

CD4+ Tregs and immune control

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Principles and use of anti-CTLA4 antibody in human cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

The central role of CD4(+) T cells in the antitumor immune response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Tumor necrosis factor (TNF).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Structure of tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Selective targeted delivery of TNFalpha to tumor blood vessels.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Multiple defects of immune cell function in mice with disrupted interferon-gamma genes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737450

7 January 2021

Identifiers

DOI

10.1002/EJI.200737450

1 reference

19 April 2018

release_dqkvwis2sjhsbfplgbutqp7qam

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dqkvwis2sjhsbfplgbutqp7qam

24 November 2022

mapped directly with Wikidata item

1 reference

19 April 2018